Catalyst Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CPRX and other ETFs, options, and stocks.

About CPRX

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), MuSK antibody positive myasthenia gravis, spinal muscular atrophy (SMA) type 3, and infantile spasms. The company was founded by Huckel E. 

CEO
Patrick J. McEnany
CEOPatrick J. McEnany
Employees
76
Employees76
Headquarters
Coral Gables, Florida
HeadquartersCoral Gables, Florida
Founded
2002
Founded2002
Employees
76
Employees76

CPRX Key Statistics

Market cap
1.68B
Market cap1.68B
Price-Earnings ratio
26.48
Price-Earnings ratio26.48
Dividend yield
Dividend yield
Average volume
4.60M
Average volume4.60M
High today
$16.22
High today$16.22
Low today
$15.66
Low today$15.66
Open price
$15.72
Open price$15.72
Volume
1.69M
Volume1.69M
52 Week high
$22.11
52 Week high$22.11
52 Week low
$5.58
52 Week low$5.58

CPRX Earnings

$0.00
$0.09
$0.19
$0.28
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
$0.20 per share
Estimated$0.20 per share
Actual
Expected Mar 15, After Hours
ActualExpected Mar 15, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.